Dapagliflozin Evaluation on Atrial Fibrillation Patients Followed Cox Maze IV Procedure

NCT05816733 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

348

Enrollment

OTHER

Sponsor class

Conditions

Atrial Fibrillation Recurrence
Cox Maze IV
Atrial Fibrillation
Patients With or Without Heart Failure and Diabetes

Interventions

DRUG: Dapagliflozin
DRUG: Placebo

Sponsor

Kun Hua